Dark Forest Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Dark Forest Capital Management’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,954	Closed	-$191K	–	1662
2022 Q4	$191K	Buy	18,954 +7,242	+62%	+$72.5K	0.05%	269
2022 Q3	$116K	Buy	+11,712	New	+$116K	0.02%	456
2022 Q1	–	Sell	-74,328	Closed	-$732K	–	1937
2021 Q4	$732K	Hold	74,328	–	–	0.27%	94
2021 Q3	$724K	Buy	+74,328	New	+$720K	0.26%	85

Dark Forest Capital Management's BIOT Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 18,954 shares — an estimated $191K sold.

Dark Forest Capital Management first reported a position in BIOT in Q3 2021 and held it in 4 quarters. The position peaked at $732K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Dark Forest Capital Management reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Dark Forest Capital Management sold 18,954 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $191K.
Dark Forest Capital Management first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q3 2021 and held it in 4 quarters.
Dark Forest Capital Management's Biotech Acquisition Company Class A Ordinary Shares position peaked at $732K in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.